Clinical trials
Neonatal Hyperbilirubinemia clinical trials
Below are recruiting neonatal hyperbilirubinemia clinical trials, each written for real people, not researchers. We’re tracking 10 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06517862RecruitingPhase 4
Extra medicines with light therapy for newborn jaundice
This trial tests if giving a zinc or bile acid medicine alongside light therapy helps break down jaundice faster in newborns. It could shorten treatment time for babies who need phototherapy in their first week of life.
Cairo, Cairo GovernorateAges 1 day–1 month - NCT07110987Recruiting
Adding a Medicine to Light Therapy for Newborn Jaundice
This study tests whether adding a medicine called Ursodeoxycholic Acid (UDCA) to standard light therapy (phototherapy) helps treat newborn jaundice more quickly. Jaundice causes yellow skin and eyes, and this trial looks at babies whose jaundice is severe enough to need light treatment.
LatakiaAges Up to 1 month - NCT07102836RecruitingPhase 2
Zinc vs probiotics for jaundice in newborns on light therapy
This trial tests whether zinc or probiotics can help babies with jaundice recover faster while receiving phototherapy (light treatment). It aims to find a safe, easy way to lower bilirubin levels.
Bahawalpur, Punjab ProvinceAges birth–4 weeks - NCT07690930Enrolling by invitation
Hat glasses for eye protection during jaundice light therapy
This trial tests a special hat-like glasses to protect babies' eyes during phototherapy (light treatment for jaundice). It is for healthy full-term newborns who are in a regular hospital room.
KaramanAges birth–4 weeks - NCT03866213Recruiting
Test a jaundice device for newborns in low-resource settings
This trial checks whether a new device can accurately detect and track yellowing of the skin (newborn jaundice) in hospitals with limited resources. It may help clinicians monitor jaundice and decide on treatments like blue light therapy more reliably.
Houston, TexasAges birth–4 weeks - NCT06832800RecruitingEarly Phase 1
Testing a new tool to manage jaundice in newborns
This trial uses a special breath test (ETCOc) to measure jaundice in newborns, aiming to improve diagnosis and treatment. It may help doctors decide when treatment is needed.
HangzhouAges 4 hours–4 weeks - NCT07346976Recruiting
Jaundice management study using carbon monoxide breath test in newborns
This study uses a simple breath test to measure carbon monoxide levels in newborns, which may help doctors better manage jaundice. It aims to understand how these levels change and how they relate to jaundice treatment.
Yiwu, ZhejiangAges birth–4 weeks - NCT07761689Recruiting
Kangaroo care for pain relief during newborn jaundice light therapy
This study tests whether holding your baby skin-to-skin (kangaroo care) during light therapy for jaundice can help reduce their pain and discomfort. It aims to see if this simple comfort measure is beneficial.
IstanbulAges 2 days–1 week - NCT04218318Recruiting
Stopping light therapy early in newborns with blood breakdown
This study looks for a safe threshold to stop the “light therapy” (phototherapy) in newborns who have jaundice caused by blood cell breakdown (hemolytic disease). It may help some babies avoid unnecessary extra days of treatment while still staying safe.
MadinahAges 1 hour–2 weeks - NCT06702241RecruitingPhase 2/Phase 3
Light therapy for newborn jaundice
This trial tests different ways to give light therapy to newborns with jaundice. It compares different approaches to see which is best, and may help parents understand the most effective treatment for their baby.
AalborgAges 1 day–2 weeks
Hear when a new Neonatal Hyperbilirubinemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neonatal hyperbilirubinemia?
- Yes. Clin2 currently lists 10 recruiting neonatal hyperbilirubinemia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neonatal hyperbilirubinemia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neonatal hyperbilirubinemia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.